Roivant Sciences Ltd. (ROIV) Misses Q2 EPS by 2c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.25), $0.02 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $4.48 million versus the consensus estimate of $48.63 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Lockheed, RTX, Boeing, L3Harris expected to meet with Trump - WSJ
• Venezuela oil export revenue rises 21.5% in first quarter